We are joined by Imran Eba of GlaxoSmithKline's Bioelectronic Medicine fund - Action Potential Venture Capital to talk about investing in Bioelectronic Medicines. APV is the only fund that invests exclusively in bioelectronic medicines - and they've been here since the beginning.

This leads to the ongoing question: what is and what is not a bioelectronic medicine (hear all three answers.)

After we get through the personal grooming habits of the hosts and our guest as well as the obligatory cricket references (it's hard to put JoJo on her heels in professional sports parlance - but Arun and Imran manage to  keep her quiet for a record time) we launch into a casual conversation about what's happening in neurotech investing.

We talk about the trials and tribulations of how the world perceives Bioelectronic Medicines, what it should be, and what the reality is. Generously, Imran also shares with us some insights that every investigator, inventor, and investor should consider when preparing to raise funds in the field of neurotechnology, wait, no - BCIs, no -neuromodulation, gah - I mean... bioelectronic medicine.

And if you are looking for the framework for Bioelectronic Medicine that we discuss, you can get it here.

Special thanks to our sound engineer, Mr. Swaminathan ThiruGnanaSambandam for his artsy work on audio mixing/mastering and sound design for this episode.

Special thanks to our sponsors, CorTec Neuro & Cirtec Medical.

Podchaser: 6xQc3dDQaIFab7JcLAab